Zoznam všetkých zadávateľov

Zobrazuji zprávy od zadavatele: ITM Isotopen Technologien München AG

Nalezeno zpráv: 2

Isotope Technologies Garching GmbH announces in-licensing of DOTA-Zoledronate for Bone Targeted Radionuclide Theranostics of Osseous Metastases

20.08.2015 14:25

Zadavatel: ITM Isotopen Technologien München AG

Isotope Technologies Garching announces successful Validation of EndolucinBetaTM (n.c.a. Lutetium-177) Marketing Authorization Application by the European Medicines Agency

04.06.2015 12:06

Zadavatel: ITM Isotopen Technologien München AG

Nalezeno zpráv: 2